Maribeth C. Lovegrove

5.0k total citations · 3 hit papers
38 papers, 3.4k citations indexed

About

Maribeth C. Lovegrove is a scholar working on Emergency Medicine, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Maribeth C. Lovegrove has authored 38 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Emergency Medicine, 11 papers in Pediatrics, Perinatology and Child Health and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Maribeth C. Lovegrove's work include Poisoning and overdose treatments (15 papers), Pharmaceutical studies and practices (10 papers) and Opioid Use Disorder Treatment (9 papers). Maribeth C. Lovegrove is often cited by papers focused on Poisoning and overdose treatments (15 papers), Pharmaceutical studies and practices (10 papers) and Opioid Use Disorder Treatment (9 papers). Maribeth C. Lovegrove collaborates with scholars based in United States, Uganda and Malta. Maribeth C. Lovegrove's co-authors include Daniel S. Budnitz, Nadine Shehab, Chesley Richards, Andrew I. Geller, Nina J. Weidle, Kathleen Rose, Alexander E. Crosby, Robert P. Mozersky, Babgaleh B. Timbo and Beverly J. Wolpert and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Maribeth C. Lovegrove

38 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emergency Hospitalizations for Adverse Drug Events in Older Americans

2011 1.3k citations Daniel S. Budnitz, Maribeth C. Lovegrove et al. New England Journal of Medicine profile →
US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014

2016 466 citations Nadine Shehab, Maribeth C. Lovegrove et al. profile →
Emergency Department Visits for Adverse Events Related to Dietary Supplements

2015 321 citations Andrew I. Geller, Nadine Shehab et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maribeth C. Lovegrove United States	20	1.1k	585	565	461	459	38	3.4k
Nadine Shehab United States	27	1.5k 1.3×	986 1.7×	617 1.1×	603 1.3×	715 1.6×	42	5.1k
Martin Schulz Germany	31	957 0.9×	537 0.9×	185 0.3×	341 0.7×	538 1.2×	155	4.1k
Carl M. J. Kirkpatrick Australia	45	1.1k 1.0×	469 0.8×	744 1.3×	434 0.9×	767 1.7×	210	7.7k
Robert L. Page United States	36	828 0.8×	1.8k 3.0×	326 0.6×	543 1.2×	359 0.8×	147	4.9k
Mariam Molokhia United Kingdom	30	413 0.4×	556 1.0×	454 0.8×	325 0.7×	370 0.8×	89	3.8k
Peter A. G. M. De Smet Netherlands	37	1.2k 1.1×	346 0.6×	327 0.6×	479 1.0×	503 1.1×	166	4.7k
Gillian E. Caughey Australia	32	2.0k 1.9×	968 1.7×	371 0.7×	1.1k 2.4×	347 0.8×	162	5.6k
Katja Taxis Netherlands	32	1.5k 1.4×	375 0.6×	191 0.3×	481 1.0×	421 0.9×	192	3.6k
Flora M. Haaijer‐Ruskamp Netherlands	36	1.4k 1.3×	645 1.1×	350 0.6×	1.2k 2.5×	496 1.1×	150	4.5k
Daniel S. Budnitz United States	33	2.1k 1.9×	946 1.6×	678 1.2×	733 1.6×	1.1k 2.4×	70	6.7k

Countries citing papers authored by Maribeth C. Lovegrove

Since Specialization

Citations

This map shows the geographic impact of Maribeth C. Lovegrove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maribeth C. Lovegrove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maribeth C. Lovegrove more than expected).

Fields of papers citing papers by Maribeth C. Lovegrove

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maribeth C. Lovegrove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maribeth C. Lovegrove. The network helps show where Maribeth C. Lovegrove may publish in the future.

Co-authorship network of co-authors of Maribeth C. Lovegrove

This figure shows the co-authorship network connecting the top 25 collaborators of Maribeth C. Lovegrove. A scholar is included among the top collaborators of Maribeth C. Lovegrove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maribeth C. Lovegrove. Maribeth C. Lovegrove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lovegrove, Maribeth C., Nimalie D. Stone, Andrew I. Geller, et al.. (2025). U.S. Emergency Department Visits Attributed by Clinicians to Semaglutide Adverse Events, 2022–2023. Annals of Internal Medicine. 178(6). 898–900. 2 indexed citations

Lovegrove, Maribeth C., Nina J. Weidle, Andrew I. Geller, et al.. (2023). Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures. American Journal of Preventive Medicine. 64(6). 834–843. 3 indexed citations

Geller, Andrew I., Daniel C. Ehlman, Maribeth C. Lovegrove, & Daniel S. Budnitz. (2022). National estimates of emergency department visits for medication-related self-harm: United States, 2016–2019. Injury Prevention. 28(6). 545–552. 4 indexed citations

Geller, Andrew I., Maribeth C. Lovegrove, Jennifer N. Lind, Samik Datta, & Daniel S. Budnitz. (2021). Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by US Retail Pharmacies During the Pandemic. JAMA Internal Medicine. 181(6). 869–869. 5 indexed citations

Moro, Ruth N., Andrew I. Geller, Nina J. Weidle, et al.. (2020). Emergency Department Visits Attributed to Adverse Events Involving Benzodiazepines, 2016–2017. American Journal of Preventive Medicine. 58(4). 526–535. 14 indexed citations

Shehab, Nadine, Maribeth C. Lovegrove, & Daniel S. Budnitz. (2020). US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020. JAMA Internal Medicine. 180(10). 1384–1384. 20 indexed citations

Lovegrove, Maribeth C., Robert J. Geller, Adam C. Pomerleau, et al.. (2020). Circumstances Involved in Unsupervised Solid Dose Medication Exposures among Young Children. The Journal of Pediatrics. 219. 188–195.e6. 10 indexed citations

Geller, Andrew I., Deborah Dowell, Maribeth C. Lovegrove, et al.. (2019). U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016. American Journal of Preventive Medicine. 56(5). 639–647. 21 indexed citations

Geller, Andrew I., Maribeth C. Lovegrove, Nadine Shehab, et al.. (2018). National Estimates of Emergency Department Visits for Antibiotic Adverse Events Among Adults—United States, 2011–2015. Journal of General Internal Medicine. 33(7). 1060–1068. 40 indexed citations

10.

Lovegrove, Maribeth C., Nina J. Weidle, & Daniel S. Budnitz. (2018). Ingestion of Over-the-Counter Liquid Medications: Emergency Department Visits by Children Aged Less Than 6 Years, 2012–2015. American Journal of Preventive Medicine. 56(2). 288–292. 5 indexed citations

11.

Lovegrove, Maribeth C., et al.. (2017). Primary Care Provider Perceptions and Practices Regarding Dosing Units for Oral Liquid Medications. Academic Pediatrics. 18(4). 405–408. 3 indexed citations

12.

Budnitz, Daniel S., Maribeth C. Lovegrove, Mathew R. P. Sapiano, et al.. (2016). Notes from the Field:Pediatric Emergency Department Visits for Buprenorphine/Naloxone Ingestion — United States, 2008–2015. MMWR Morbidity and Mortality Weekly Report. 65(41). 1148–1149. 23 indexed citations

13.

Geller, Andrew I., Nadine Shehab, Nina J. Weidle, et al.. (2015). Emergency Department Visits for Adverse Events Related to Dietary Supplements. New England Journal of Medicine. 373(16). 1531–1540. 321 indexed citations breakdown →

14.

Lovegrove, Maribeth C., Lee M. Hampton, Daniel S. Budnitz, & Andrew I. Geller. (2013). Emergency Department Visits and Hospitalizations for Buprenorphine Ingestion by Children — United States, 2010–2011. PubMed Central. 62. 10 indexed citations

15.

Lovegrove, Maribeth C., et al.. (2013). Efficacy of Flow Restrictors in Limiting Access of Liquid Medications by Young Children. The Journal of Pediatrics. 163(4). 1134–1139.e1. 22 indexed citations

16.

Drexler, Naomi A., et al.. (2012). Secondary Mapping of Lymphatic Filariasis in Haiti-Definition of Transmission Foci in Low-Prevalence Settings. PLoS neglected tropical diseases. 6(10). e1807–e1807. 19 indexed citations

17.

Budnitz, Daniel S., Maribeth C. Lovegrove, Nadine Shehab, & Chesley Richards. (2011). Emergency Hospitalizations for Adverse Drug Events in Older Americans. New England Journal of Medicine. 365(21). 2002–2012. 1268 indexed citations breakdown →

18.

Manthripragada, Angelika D., Esther H. Zhou, Daniel S. Budnitz, Maribeth C. Lovegrove, & Mary E. Willy. (2011). Characterization of acetaminophen overdose‐related emergency department visits and hospitalizations in the United States. Pharmacoepidemiology and Drug Safety. 20(8). 819–826. 62 indexed citations

19.

Budnitz, Daniel S., Maribeth C. Lovegrove, & Alexander E. Crosby. (2011). Emergency Department Visits for Overdoses of Acetaminophen-Containing Products. American Journal of Preventive Medicine. 40(6). 585–592. 144 indexed citations

20.

Streit, Thomas G., Heather A. Boyd, Michael J. Beach, et al.. (2004). Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence. PubMed. 3(1). 3–3. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact